Abstract:Cardiac channelopathies are a group of inherited syndromes that can cause malignant arrhythmias and sudden cardiac death, particularly in the pediatric population. Today, a 12-lead electrocardiogram is the most effective tool to diagnose these diseases. Incomplete penetrance and variable expressivity are hallmarks of these syndromes. Some of these malignant entities may remain hidden and only a trigger such as exercise, emotions or fever can unmask the electrical pattern to diagnose the disease. Sudden cardiac death may be the first manifestation of any of these syndromes. The use of complementary tests that allow early diagnosis is strongly recommended, among which we find: pharmacological provocations, exercise tests, and genetic analysis. Genetic testing makes it possible to unravel the origin of the disease, and also identify family members who carry the harmful genetic defect and are therefore at risk. One of the main challenges in this area is the large number of genetic variants of uncertain significance, which prevent effective translation into clinical practice. Early identification of the pediatric population at risk and adequate risk stratification are crucial to adopting personalized preventive measures that reduce the risk of lethal episodes in this population. What is Known: • In the pediatric population, malignant arrhythmias leading to sudden cardiac death are mainly caused by inherited syndromes. • A conclusive genetic diagnosis unravels the origin of the syndrome and allows cascade screening to identify relatives carrying the genetic alteration. What is New: • The use of sequencing technologies allows a broad genetic analysis, helping to unravel new genetic alterations causing inherited arrhythmogenic syndromes. • A periodic reanalysis of genetic variants that currently have an ambiguous role will help discern those that are truly pathogenic.

Genetics of sudden death: focus on inherited channelopathies

Ion Channel Disorders and Sudden Cardiac Death

The Genetic Basis of Sudden Cardiac Death: From Diagnosis to Emerging Genetic Therapies

Inherited conditions of arrhythmia: translating disease mechanisms to patient management

Incomplete Penetrance and Variable Expressivity: Hallmarks in Channelopathies Associated with Sudden Cardiac Death

Cardiac channelopathies in pediatrics: a genetic update

Pathogenesis and Clinical Characteristics of Hereditary Arrhythmia Diseases

Sudden Cardiac Death and Channelopathies: What Lies Behind the Clinical Significance of Rare Splice-Site Alterations in the Genes Involved?

Modifier genes for sudden cardiac death

[Cardiac channelopathies in the context of hereditary arrhythmia syndromes]

Primary Electrical Heart Disease—Principles of Pathophysiology and Genetics

Cardiogenetics: the role of genetic testing for inherited arrhythmia syndromes and sudden death

Gene mutations in comorbidity of epilepsy and arrhythmia

The Kir2.1-Na V 1.5 Channelosome and its role in Arrhythmias in Inheritable Cardiac Diseases

Opportunities for sudden death prevention: Directions for new clinical and basic research

Precision Medicine and Cardiac Channelopathies: Human iPSCs Take the Lead

[Postmortem genetic testing in sudden cardiac death due to ion channelopathies]

Arrhythmic Sudden Cardiac Death in Heart Failure With Preserved Ejection Fraction: Mechanisms, Genetics, and Future Directions

Retrospective Molecular Analysis in Five Cases Probably Associated with Sudden Death the National Institute of Legal Medicine and Forensic Sciences of Colombia

The proarrhythmogenic role of autonomics and emerging neuromodulation approaches to prevent sudden death in cardiac ion channelopathies

Investigating cardiac genetic background in sudden infant death syndrome (SIDS)